Scientific Literature Search

Source record

Neuropeptides, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor-receptor interactions. Relevance for Parkinson's disease and schizophrenia.

Fuxe K, Agnati LF, von Euler G, Tanganelli S, O'Connor WT, Ferré S, Hedlund P, Zoli M.

Neurochem Int · 1992-03-01

DOI: 10.1016/0197-0186(92)90242-jPMID: 1365429

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The MPTP-treated mouse as a model of parkinsonism: how good is it?

Heikkila RE, Sonsalla PK.

Neurochem Int · 1992-03-01

DOI: 10.1016/0197-0186(92)90256-qPMID: 1365446

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Clinical classification of dopaminergic effects in parkinsonism.

Horowski R, Runge I.

Neurochem Int · 1992-03-01

DOI: 10.1016/0197-0186(92)90261-oPMID: 1365452

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Parkinsonism treatment: Part III--Update.

Collier DS, Berg MJ, Fincham RW.

Ann Pharmacother · 1992-02-01

DOI: 10.1177/106002809202600218PMID: 1348193

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Frequency and cause of Parkinson's disease.

Rajput AH.

Can J Neurol Sci · 1992-02-01

DOI: 10.1017/s0317167100041457PMID: 1571854

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

A rationale for dopamine agonists as primary therapy for Parkinson's disease.

Olanow CW.

Can J Neurol Sci · 1992-02-01

PMID: 1349262

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Prevention and management of late stage complications in Parkinson's disease.

Stoessl AJ.

Can J Neurol Sci · 1992-02-01

DOI: 10.1017/s0317167100041470PMID: 1571855

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: phylogenetic disorders of the human neocortex sharing many characteristics.

Eisen A, Calne D.

Can J Neurol Sci · 1992-02-01

PMID: 1571856

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Interactions between MPTP-induced and age-related neuronal death in a murine model of Parkinson's disease.

Tatton WG, Greenwood CE, Seniuk NA, Salo PT.

Can J Neurol Sci · 1992-02-01

DOI: 10.1017/s0317167100041494PMID: 1571857

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Positron emission tomography in Parkinson's disease.

Snow BJ.

Can J Neurol Sci · 1992-02-01

DOI: 10.1017/s0317167100041512PMID: 1571859

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Deprenyl in Parkinson's disease: mechanisms, neuroprotective effect, indications and adverse effects.

Vezina P, Mohr E, Grimes D.

Can J Neurol Sci · 1992-02-01

DOI: 10.1017/s0317167100041524PMID: 1571860

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson's disease: sites of action and implications for the pathogenesis of dyskinesias.

Robertson HA.

Can J Neurol Sci · 1992-02-01

DOI: 10.1017/s0317167100041536PMID: 1349263

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

41.185 articles found

Neuropeptides, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor-receptor interactions. Relevance for Parkinson's disease and schizophrenia.

The MPTP-treated mouse as a model of parkinsonism: how good is it?

Clinical classification of dopaminergic effects in parkinsonism.

Parkinsonism treatment: Part III--Update.

Frequency and cause of Parkinson's disease.

A rationale for dopamine agonists as primary therapy for Parkinson's disease.

Prevention and management of late stage complications in Parkinson's disease.

Amyotrophic lateral sclerosis, Parkinson's disease and Alzheimer's disease: phylogenetic disorders of the human neocortex sharing many characteristics.

Interactions between MPTP-induced and age-related neuronal death in a murine model of Parkinson's disease.

Positron emission tomography in Parkinson's disease.

Deprenyl in Parkinson's disease: mechanisms, neuroprotective effect, indications and adverse effects.

Synergistic interactions of D1- and D2-selective dopamine agonists in animal models for Parkinson's disease: sites of action and implications for the pathogenesis of dyskinesias.

Filters